Min Dong

1.8k total citations
73 papers, 1.4k citations indexed

About

Min Dong is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Min Dong has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Epidemiology and 22 papers in Hepatology. Recurrent topics in Min Dong's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (13 papers) and Cancer, Lipids, and Metabolism (12 papers). Min Dong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (13 papers) and Cancer, Lipids, and Metabolism (12 papers). Min Dong collaborates with scholars based in China, United States and Australia. Min Dong's co-authors include Qu Lin, Zhan‐Hong Chen, Xing Li, Chun‐Kui Shao, Jianning Chen, Xiaokun Ma, Jing Liu, Wen‐Wu Li, Xiaorong Sun and Jinming Yu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Brain Research.

In The Last Decade

Min Dong

69 papers receiving 1.4k citations

Peers

Min Dong
Junting Huang China
Kenji Okita Japan
Kyueng‐Whan Min South Korea
Francesc Alameda Spain
R J Davies United Kingdom
Kazumasa Takenaka Japan
Yanxin Luo China
Kenichiro Watanabe Japan
Feng‐Ming Hsu Taiwan
Junting Huang China
Min Dong
Citations per year, relative to Min Dong Min Dong (= 1×) peers Junting Huang

Countries citing papers authored by Min Dong

Since Specialization
Citations

This map shows the geographic impact of Min Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Dong more than expected).

Fields of papers citing papers by Min Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Dong. The network helps show where Min Dong may publish in the future.

Co-authorship network of co-authors of Min Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Min Dong. A scholar is included among the top collaborators of Min Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Dong. Min Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dong, Min, et al.. (2025). MSA-LR: Enhancing multi-scale temporal dynamics in multivariate time series forecasting with low-rank self-attention. Neural Networks. 194. 108150–108150. 1 indexed citations
3.
Liu, Mengmeng, et al.. (2024). Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer. Breast Cancer. 31(2). 317–328. 1 indexed citations
4.
Xiao, Yi, Jinyuan He, Min Dong, et al.. (2022). Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study. Frontiers in Oncology. 12. 820302–820302. 14 indexed citations
5.
Zhang, Yi, et al.. (2020). Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer. Clinics. 75. e993–e993. 23 indexed citations
6.
Li, Zixiong, et al.. (2019). Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer. Journal of Cellular Physiology. 234(11). 20584–20602. 28 indexed citations
7.
8.
Cai, Xiurong, Zhan‐Hong Chen, Xiaoping Zhang, et al.. (2018). Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy. Journal of Cancer. 9(13). 2380–2388. 12 indexed citations
9.
Liu, Jie, Xuliang Zhang, Chang Ma, et al.. (2017). The Hsp90 inhibitor 17-DMAG decreases infection of porcine circovirus type 2 in mice. Microbial Pathogenesis. 109. 248–252. 5 indexed citations
10.
Zhang, Xiaofang, Min Dong, Yuhang Pan, et al.. (2017). Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma. Human Pathology. 65. 92–100. 48 indexed citations
11.
Liu, Jing, Min Dong, Xiaorong Sun, et al.. (2016). Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS ONE. 11(1). e0146195–e0146195. 147 indexed citations
12.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2016). Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization. Asian Pacific Journal of Cancer Prevention. 16(18). 8665–8670. 10 indexed citations
13.
14.
Chen, Jie, Qu Lin, Xing Li, et al.. (2014). Prognosis value of mitotic kinase Aurora-A for primary duodenal adenocarcinoma. Tumor Biology. 35(9). 9361–9370. 4 indexed citations
15.
Dong, Min, Xinjuan Fan, Zhan‐Hong Chen, et al.. (2014). Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer. Oncology Reports. 32(3). 1101–1107. 14 indexed citations
16.
Li, Xing, Zhan‐Hong Chen, Xiaokun Ma, et al.. (2014). Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biology. 35(11). 11057–11063. 35 indexed citations
17.
Dong, Min, Xiang‐Bo Wan, Wei Li, et al.. (2013). Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Medical Oncology. 30(1). 355–355. 43 indexed citations
18.
Wu, Xiangyuan, Xing Li, Zhan‐Hong Chen, et al.. (2012). An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study. Tumor Biology. 34(2). 909–918. 7 indexed citations
19.
Liu, Zhaoqian, Linyong Xu, Zhicheng Gong, et al.. (2011). Association of plasma epinephrine level with insulin sensitivity in metabolically healthy but obese individuals. Autonomic Neuroscience. 167(1-2). 66–69. 8 indexed citations
20.
Li, Xing, Qu Lin, Min Dong, et al.. (2010). Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. Leukemia & lymphoma. 51(9). 1678–1685. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junting Huang Breakdown of academic impact, for papers by Kenji Okita Breakdown of academic impact, for papers by Kyueng‐Whan Min Breakdown of academic impact, for papers by Francesc Alameda Breakdown of academic impact, for papers by R J Davies Breakdown of academic impact, for papers by Kazumasa Takenaka Breakdown of academic impact, for papers by Yanxin Luo Breakdown of academic impact, for papers by Kenichiro Watanabe Breakdown of academic impact, for papers by Feng‐Ming Hsu
Rankless by CCL
2026